These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20821751)

  • 1. You can win by losing: p53 mutations in rhabdomyosarcomas.
    Post SM; Lozano G
    J Pathol; 2010 Oct; 222(2):124-8. PubMed ID: 20821751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
    Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
    J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
    Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL
    Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
    Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
    Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.
    Ianzano ML; Croci S; Nicoletti G; Palladini A; Landuzzi L; Grosso V; Ranieri D; Dall'Ora M; Santeramo I; Urbini M; De Giovanni C; Lollini PL; Nanni P
    Oncotarget; 2014 Jan; 5(1):108-19. PubMed ID: 24334679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhabdomyosarcoma development in Trp53/fos mutant mice: tumor suppressor functions of the Fos protooncogene].
    Jochum W
    Verh Dtsch Ges Pathol; 2004; 88():224-30. PubMed ID: 16892556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.
    Keller C; Arenkiel BR; Coffin CM; El-Bardeesy N; DePinho RA; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2614-26. PubMed ID: 15489287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
    Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
    Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
    Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
    Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
    Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications.
    Nakahata K; Simons BW; Pozzo E; Shuck R; Kurenbekova L; Prudowsky Z; Dholakia K; Coarfa C; Patel TD; Donehower LA; Yustein JT
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35174853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of p53 gene in soft tissue and bone tumors.
    Roessner A; Schneider-Stock R; Radig K; Neumann W; Mittler U
    Gen Diagn Pathol; 1997 Jul; 143(1):1-13. PubMed ID: 9269903
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart.
    Garcia JM; Gonzalez R; Silva JM; Dominguez G; Vegazo IS; Gamallo C; Provencio M; EspaƱa P; Bonilla F
    Br J Cancer; 2000 Mar; 82(6):1183-5. PubMed ID: 10735503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of p53 gene in childhood malignant solid tumors.
    Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
    J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
    Tsintari V; Walter B; Fend F; Overkamp M; Rothermundt C; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
    BMC Cancer; 2022 Jul; 22(1):725. PubMed ID: 35780096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric nonrhabdomyosarcoma soft tissue sarcomas: progress on clinical and biologic fronts.
    Wexler LH; Garvin JH
    J Pediatr; 1997 Oct; 131(4):508-9. PubMed ID: 9386647
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical analysis for Mdm2 and p53 proteins in methylcholanthrene-induced mouse rhabdomyosarcomas.
    Wu H; Inoue M
    J Vet Med Sci; 2006 May; 68(5):427-31. PubMed ID: 16757884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mutant p53 in human cancer.
    Goh AM; Coffill CR; Lane DP
    J Pathol; 2011 Jan; 223(2):116-26. PubMed ID: 21125670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.